We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of COVID-19 Vaccine

Product News   Apr 27, 2021

 
Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of COVID-19 Vaccine

Credit: torstensimon/ Pixabay

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2(R)

Product News

Orgenesis Inc. announces it has been granted Investigational Device Exemption (IDE) approval by the United States Food and Drug Administration (FDA) to conduct a first-in-human feasibility study of the Tissue Genesis Icellator2(R) to treat Acute Respiratory Distress Syndrome (ARDS) resulting from COVID-19 infection.

READ MORE

Lonza Announces Results of the 2021 Annual General Meeting

Product News

Lonza Group Ltd has hosted its Annual General Meeting, led by the Chairman of the Board of Directors, Albert M. Baehny.

READ MORE

DefiniGEN Appoints Chairman to Further Expand Preclinical Drug Development Capabilities

Product News

DefiniGEN has announced the appointment of Dr Ben Cons as Chairman of the Board. A respected entrepreneur and pharmaceutical and healthcare leader, he has a proven track record and brings more than 30 years’ experience in pharmaceutical R&D & commercialization across the biotech, pharmaceutical and financing sectors.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE